The procoagulant phospholipid dependent clotting time and the initiation phase of thrombin generation test are mandatory for the evaluation of the risk for severe early onset preeclampsia

Affiliations

• ¹ Sorbonne Université, INSERM, UMR_S 938, Centre de recherche Saint-Antoine (CRSA), Research Group "Cancer, Biology and Therapeutics", Research Team "Cancer, Haemostasis, Angiogenesis", Paris, France; Clinical Research Department, Stago, Gennevilliers, France.
• ² Sorbonne Université, INSERM, UMR_S 938, Centre de recherche Saint-Antoine (CRSA), Research Group "Cancer, Biology and Therapeutics", Research Team "Cancer, Haemostasis, Angiogenesis", Paris, France; Perigenesis, Institute of Obstetric Haematology, Thessaloniki, Greece.
• ³ Sorbonne Université, INSERM, UMR_S 938, Centre de recherche Saint-Antoine (CRSA), Research Group "Cancer, Biology and Therapeutics", Research Team "Cancer, Haemostasis, Angiogenesis", Paris, France.
• ⁴ Centre for Human Reproduction, Genesis Athens Clinic, Athens, Greece.
• ⁵ Sorbonne Université, INSERM, UMR_S 938, Centre de recherche Saint-Antoine (CRSA), Research Group "Cancer, Biology and Therapeutics", Research Team "Cancer, Haemostasis, Angiogenesis", Paris, France; Institut Universitaire de Cancérologie, Assistance Publique - Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France. Electronic address: grigorios.gerotziafas@inserm.fr.